Drugs / Autologous Mesenchymal Bone Marrow Cell
Autologous Mesenchymal Bone Marrow Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02570932 | Jul 2015 → Dec 2017 | spinal cord injury | Puerta de Hierro University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Mesenchymal Bone Marrow Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02570932 ↗ |
| Modality | Cell therapy | “in vitro expanded autologous adult bone marrow mesenchymal stem cells” NCT02570932 ↗ |
| Route | Intrathecal | “Route of administration: Intrathecal in subarachnoid space by lumbar puncture.” NCT02570932 ↗ |